Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 296

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases

Open access
Kohutek, Zachary A., Yamada, Yoshiya, Chan, Timothy A., Brennan, Cameron W., Tabar, Viviane, Gutin, Philip H., Jonathan Yang, T., Rosenblum, Marc K., Ballangrud, Åse, Young, Robert J., Zhang, Zhigang, Beal, Kathryn · 2015 · Journal of Neuro-Oncology

Abstract

Radionecrosis is a well-characterized effect of stereotactic radiosurgery (SRS) and is occasionally associated with serious neurologic sequelae. Here, we investigated the incidence of and clinical variables associated with the development of radionecrosis and related radiographic changes after SRS for brain metastases in a cohort of patients with long-term follow up. 271 brain metastases treated with single-fraction linear accelerator-based SRS were analyzed. Radionecrosis was diagnosed either pathologically or radiographically. Univariate and multivariate Cox regression was performed to determine the association between radionecrosis and clinical factors available prior to treatment planning. After median follow up of 17.2 months, radionecrosis was observed in 70 (25.8 %) lesions, including 47 (17.3 %) symptomatic cases. 22 of 70 cases (31.4 %) were diagnosed pathologically and 48 (68.6 %) were diagnosed radiographically. The actuarial incidence of radionecrosis was 5.2 % at 6 months, 17.2 % at 12 months and 34.0 % at 24 months. On univariate analysis, radionecrosis was associated with maximum tumor diameter (HR 3.55, p < 0.001), prior whole brain radiotherapy (HR 2.21, p = 0.004), prescription dose (HR 0.56, p = 0.02) and histology other than non-small cell lung, breast or melanoma (HR 1.85, p = 0.04). On multivariate analysis, only maximum tumor diameter (HR 3.10, p < 0.001) was associated with radionecrosis risk. This data demonstrates that with close imaging follow-up, radionecrosis after single-fraction SRS for brain metastases is not uncommon. Maximum tumor diameter on pre-treatment MR imaging can provide a reliable estimate of radionecrosis risk prior to treatment planning, with the greatest risk among tumors measuring >1 cm.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11060-015-1881-3

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 296

Metadata

Authors
Kohutek, Z. A., Yamada, Y., Chan, T. A., Brennan, C. W., Tabar, V., Gutin, P. H., Jonathan Yang, T., Rosenblum, M. K., Ballangrud, Å., Young, R. J., Zhang, Z., & Beal, K.
Venue
Journal of Neuro-Oncology
Published
2015-08-26
Volume
125
Issue
1
Pages
149-156
ISSN
  • 0167-594X (ISSN-L)
  • 1573-7373
OpenAlex
W1131275742
Cited by
296
References
24
FWCI
14.03
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases. https://app.cochat.ai/papers/10.1007/s11060-015-1881-3
The paper
Kohutek, Z. A., Yamada, Y., Chan, T. A., Brennan, C. W., Tabar, V., Gutin, P. H., Jonathan Yang, T., Rosenblum, M. K., Ballangrud, Å., Young, R. J., Zhang, Z., & Beal, K. (2015). Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-015-1881-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.